Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 9INDUSTRY 5NIH 4NETWORK 1

Study Type

Interventional 4

Sponsor

Conditions

Stomatitis 1Pneumonia 1Neoplasms 1Lupus Nephritis 1Inflammation 1Arthritis, Rheumatoid 1

Interventions

Cyclophosphamide 109Bevacizumab 97Magnetic Resonance Spectroscopy 91Specimen Handling 88Biopsy 75Paclitaxel 64fludarabine phosphate 62Immunoglobulin G 61Disulfides 61Carboplatin 58Taxes 53Cisplatin 52Doxorubicin 51fludarabine 49Sorafenib 46Radiation 46aldesleukin 45Radiotherapy 45Prednisone 45Etoposide 45Vincristine 41Sirolimus 40Platinum 40Bortezomib 38Rituximab 371,2-diaminocyclohexaneplatinum II citrate 37Nivolumab 36Cytarabine 35temsirolimus 34Vorinostat 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Has results × Etanercept × Clear all
NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
37 enrolled 20 charts

Pneumonia

NCT00837434 2021-09-22

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 4 Completed
63 enrolled 26 charts

Arthritis, Rheumatoid

NCT00031551 2017-12-06

Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
27 enrolled 10 charts

Inflammation, Neoplasms, Stomatitis

NCT00447265 2013-02-12

Etanercept for the Treatment of Lupus Nephritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Terminated
1 enrolled 15 charts

Lupus Nephritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡